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ABSTRACT. Object ive .  The accuracy and precision of the new 
I R M A  ® (Immediate Response Mobile Analysis System, Dia- 
metrics, Inc. ®, St. Paul, MN) handheld blood gas analyzer was 
compared with that of  two benchtop blood gas analyzers. The 
I R M A  consists of  a notebook-sized machine and disposable 
cartridges, each containing a pH, a CO2 and an 02 electrode, 
and provides bedside (point-of-care) blood gas analysis. 
Methods .  A total of 172 samples (arterial and mixed venous) 
were obtained from 25 informed, consenting patients under- 
going cardiopulmonary bypass. The pH, PCO2 and PO2 of  
each sample was determined on four blood gas analyzers: 
NOVA Statlabs Profile 5 (NOVA Biomedical, Waltham, MA), 
the ABL-50 (Radiometer, West Lake, OH), and two I R M A  
machines. Linear regression and bias 4- precision were deter- 
mined, comparing each of the analyzers with the NOVA. 
Results .  All three machines showed a similar, high degree of 
correlation with the NOVA for pH, PCO2, and PO2. The bias 
and precision of  the IRMA machines compared with the 
NOVA was similar to that of  the ABL compared with the 
NOVA for pH (NOVA:ABL -0.005 4- 0.011; NOVA:  I R M A  
1 = 0.0026 4- 0.025; NOVA : I R M A  2 = 0.0021 ± 0.025), for 
PCO2 (NOVA:ABL = -1 .4  4- 1.3 mmHg; N O V A : I R M A  1 
= -1 .3  4- 1.9 mmHg; NOVA : I R M A  2 = -1 .2  + 2.1 mmHg) 
and DO2 (NOVA:ABL = 3.6 ± 21.1 mmHg; NOVA : I R M A  1 
= 3.4 ± 19.9 mmHg; NOVA : I R M A  2 = 6.3 :t: 20.9 mmHg). 
The bias found for pH, PCO2, and PO2 was not affected by 
extremes of temperature (range 25.5-40°C) or hematocrit 
(range 11-44%) for any machine. Conclusions .  The new 
technology incorporated in the IR.MA blood gas analyzer 
provides results with an accuracy that is similar to that of  
benchtop analyzers, but with all of the advantages of point-of- 
care analysis. 
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In cri t ical ly ill or  anesthetized patients, the abi l i ty  to 
quant i ta t ively  assess b lood  gas status is invaluable.  Devel -  
o p m e n t  o f  the po la rographic  oxygen  elect rode in 1956 
by  Leland Clark,  and o f  the Severinghaus CO2 electrode 
shor t ly  thereafter,  made  clinical m o n i t o r i n g  o f  b l o o d  
gases a rout ine  part  o f  pat ient  care. Despi te  i m p r o v e -  
ments  in the speed w i th  which  current  bench top  ana- 
lyzers can pe r fo rm an analysis, they  are not  portable,  
requi r ing  t ranspor t  o f  b l o o d  samples to the laboratory.  
Delays in t ranspor t  or  mishand l ing  o f  the samples (e.g., 
a l lowing  air bubbles  to come in contact  w i th  the b lood ,  
too much  or  too  l i t t le hepar in  in the sample, lost labels, 
w a r m i n g  o f  the sample) can s ignif icant ly affect the accu- 
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racy of  the results or delay appropriate intervention in 
patient management [1-4]. The ability to bring the 
blood gas analyzer to the critically ill patient and to 
perform analysis at the bedside ("point-of-care") would 
alleviate many of these problems. Development of port- 
able blood gas analyzers has been limited by the require- 
ments for calibration of the CO2 electrode. Benchtop 
analyzers use known concentrations of  gas, which is 
supplied in conventional gas tanks that severely limit 
their portability. 
The new IRMA ® (Diametrics, Inc. ®, St. Paul, MN) 
handheld blood gas analyzer consists of a battery-pow- 
ered machine (approximately 12" by 15", the size of a 
notebook) and disposable cartridges, approximately 2" 
by 5" in size. The cartridges, containing a pH electrode, a 
CO2 electrode, and a polarographic 02 electrode, are 
supplied in a foil wrapper with a packet of  bicarbonate in 
a gas permeable membrane. When the foil wrapper is 
sealed, the bicarbonate equilibrates with CO2 partial 
pressure. When the cartridge is removed, the gas sur- 
rounding the CO2 and pH electrodes is the known 
partial pressure of CO2, and the electrode is calibrated 
on insertion of  the cartridge. The incorporation of  the 
calibrating gas in the foil wrapper decreases the size of 
the machine to one that can be easily hand-carried. 
While this new technology has been tested and found to 
be accurate in laboratory settings, no large-scale clinical 
trials have been reported. We therefore studied the accu- 
racy of this new blood gas analysis technology over a 
wide physiological range of  temperatures, oxygen and 
CO2 tensions, and hematocrits in patients undergoing 
cardiac surgery. 
MATERIAL AND METHODS 
With the approval of our institutional review board, 25 
patients undergoing elective cardiac surgery who gave 
informed consent were enrolled in this prospective study. 
All patients underwent placement of arterial and pulmo- 
nary artery catheters. General anesthesia was induced and 
maintained with fentanyl and midazolam infusions. All 
patients underwent systemic heparinization with 3-4  
mg of bovine heparin. Moderate hypothermic cardio- 
pulmonary bypass was employed in all patients (systemic 
cooling to a core temperature of not lower than 28 °C). 
Arterial and mixed venous blood samples were drawn 
following skin incision, after systemic cooling during 
cardiopulmonary bypass, and following successful sepa- 
ration from cardiopulmonary bypass. Six 3-ml samples 
(three arterial and three mixed venous) were collected 
from each patient into pre-heparinized syringes (Smooth- 
E @, Radiometer, West Lake, OH). Each sample was 
analyzed in randomized order in the four blood gas 
analyzers: the NOVA Statlabs Profile 5 (NOVA Biomed- 
ical, Waltham, MA); the ABL-50 (Radiometer, West 
Lake, OH); and the two IRMA machines. The order of 
analysis for each separate syringe was determined by a 
random number generator, so that order of analysis did 
not influence the results. All samples were analyzed 
within 5 minutes at room temperature and without 
cooling. Quality control measurements were performed 
daily on all analyzers using standardized control solu- 
tions (acidosis, alkalosis, and normal) in accordance with 
the College of American Pathologists' standards for ac- 
creditation. 
Data were analyzed using the statistical program Star- 
view 4.02 (Abacus Concepts, Berkeley, CA). Statistical 
analysis included linear regression and bias 4- precision as 
recommended by Bland and Altman [5]. Bias is the 
mean difference of the values and represents the system- 
atic error between two methods, while precision is the 
standard deviation of the bias and represents the random 
error. In all cases, the NOVA-6 was considered the "gold 
standard," and the other machines were compared with 
it. The bias -t- precision between the NOVA and each of  
the IRMA analyzers was compared with the bias 4- 
precision between the NOVA and the ABL for all 
variables (pH, PCO2, POe). Likewise, the correlation 
between the NOVA and each IRMA analyzer was com- 
pared with the correlation between the NOVA and the 
ABL analyzers using Fisher's z statistic. This statistic was 
modified to account for the inherent agreement resulting 
from the repetition of  the NOVA value in each compu- 
tation. 
The effect of  temperature and hematocrit on the bias 
of any machine was determined. The bias of each varia- 
ble for each analyzer compared with the NOVA was 
plotted against the hematocrit (or temperature) value of 
that sample. The correlation between the bias and the 
hematocrit (or temperature) was determined. The effect 
of hematocrit (or temperature) on the bias of the IRMA 
analyzer for each variable was compared with the effect 
on the bias demonstrated by the ABL using the Fisher's z 
statistic, again modified to account for the inherent 
agreement between samples due to the repetition of the 
NOVA value and the hematocrit (or temperature) in 
each correlation. 
RESULTS 
The pH, PCO2, and PO2 of 172 samples were deter- 
mined on each of four blood gas analyzers. Results were 
dropped from analysis when the blood gas analyzer 
failed to calibrate (twice with the IRMA machines) or 
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displayed an error message (four times with the N O V A  
and ABL). Therefore, the number  of  samples analyzed 
on each machine are different, and are detailed in the 
figures. 
All three machines showed a high degree of  correla- 
tion with the NOVA for pH (ABL r = 0.97, I R M A  1 r = 
0.89, I R M A  2 r = 0.87), for PCO2 (ABL r = 0.92, I R M A  
1 r = 0.95, I R M A  2 r = 0.91), and for PO2 (ABL r = 0.99, 
I R M A  1 r = 0.99, I R M A  2 r = 0.99). 
The bias 4- precision for each analyzer compared with 
the NOVA across the pH ranges f rom 7.00 to 7.60, as 
shown in Figure 1. While the bias of  the I R M A  analyzers 
is similar to that of  the ABL, the standard deviation 
appears larger for the I R M A  instruments (NOVA:ABL 
-0.005 + 0.011; N O V A : I R M A  1 = 0.0026 -4- 0.025; 
N O V A :  I R M A  2 = 0.0021 4- 0.025). The limits of  agree- 
ment for the I R M A  analyzers range f rom -0.04 to 
+0.044. This precision appears to be sufficient for appro- 
priate clinical decision making. 
The PCO2 analysis is shown in Figure 2. The bias and 
precision of  each analyzer compared with the N O V A  
were similar across the range of  values f rom 30 to 58 
m m H g  (NOVA:ABL = -1.38 ± 1.33 m m H g ;  N O -  
V A : I R M A  1 = -1 .26  -4- 1.87 m m H g ;  N O V A : I R M A  
2 = -1.16 -4- 2.08 mmHg) .  The range covered by the 
limits of  agreement for the I R M A  machines compared 
with the N O V A  is larger than the range comparing the 
ABL with the N O V A  (5.6 m m H g  for ABL, 7.2 m m H g  
for I R M A  1, and 8 m m H g  for I R M A  2). However,  this 
variability is unlikely to be clinically significant; 3.5% of  
the samples tested were outside of  the limits o f  agree- 
ment for PCO2 with the I R M A  machines, compared 
with 2.4% of  the values obtained with the ABL. Neither 
temperature or hematocrit  was found to affect the bias of  
either I R M A  analyzer when compared with the effect of  
temperature or hematocrit  on the bias of  the ABL. 
The PO2 analysis, as shown in Figures 3 and 4, again 
demonstrates a small bias and excellent precision for each 
machine compared with the NOVA. Figure 3 shows the 
bias and precision for PO2 values less than 100 m m H g  
and Figure 4 shows the bias and precision for values 
greater than 100 m m H g .  No differences were seen in the 
measure of  agreement with the NOVA either for the 
complete range of  oxygen tensions (NOVA:ABL = 3.6 
-t- 21.1 m m H g ;  N O V A : I R M A  1 = 3.4 -t- 19.9 m m H g ;  
N O V A : I R M A  2 = 6.3 -4- 20.9 m m H g )  or for values 
greater than 100 m m H g  (NOVA:ABL = 7.42 -4- 29.01 
m m H g ;  N O V A  : I R M A  1 = 2.11 4- 27.71 m m H g ;  N O -  
V A : I R M A  2 = 7.63 4- 29.14 mmHg) .  The ABL was 
found to have a clinically insignificant bias for PO2 
values less than 100 m m H g ,  while the two I R M A  
analyzers showed a bias of  approximately 5 m m H g  
(NOVA:ABL = -0 .3  -t- 3.9 m m H g ;  NOVA : I R M A  1 = 
4.8 ± 3.4 m m H g :  NOVA : I R M A  2 = 4.9 -4- 3.8 mmHg) .  
The precision for each analyzer appeared to be similar 
for all PO2 values, and for PO2 values greater than and 
less than 100 m m H g .  
All machines demonstrated a greater variability for 
PO2 values greater than 100 versus less than 100 mmHg.  
For PO2 values less than 100 m m H g ,  the range covered 
by the limits of  agreement were similar for all machines 
(7.8 m m H g  for ABL, 6.8 m m H g  for I R M A  1, and 7.6 
m m H g  for I R M A  2). The percentage of  values outside 
of  the limits o f  agreement was less than 5% for all 
machines (2.4% for ABL, 4.7% for I R M A  1, 4.7% for 
I R M A  2). The bias found for pH, PCO2, and PO2 was 
not affected by extremes of  temperature (range 25.5 to 
40 °C) or hematocrit  (range 11 to 44%). 
DISCUSSION 
These data demonstrate that the new technology incor- 
porated into the I R M A  blood gas analyzer provides 
blood gas results with an accuracy and precision similar 
to that of  traditional blood gas analyzers. There is an 
irreducible degree of  variability in blood gas analysis. 
Analysis of  the same blood sample repeated on the same 
machine repeatedly will produce results that are not 
identical. Therefore, this study was not concerned with 
the absolute agreement between a "new" instrument 
( IRMA) and a "gold standard" instrument (NOVA). 
Rather, it was concerned with whether the agreement 
between the "new" and the "gold standard" is different 
than the agreement between two "gold standard" instru- 
ments (NOVA and ABL). As both the ABL and the 
N O V A  analyzers are accepted as accurate and reliable 
individually, the degree of  agreement (or disagreement) 
between these two instruments must be considered ac- 
ceptable in clinical decision making. 
This study did demonstrate some differences in bias 
between the NOVA-ABL and the N O V A - I R M A ,  most 
notably in PO2 values less than 100 m m H g .  Because bias, 
or mean offset, is a systematic error, it can be corrected 
for in software algorithms, and the I R M A  company has 
developed software that enables the I R M A  to "emulate" 
any of  the standard benchtop analyzers. Precision is a 
measure of  random error, and cannot be accounted for 
with algorithms. The precision of  each of  the I R M A  
analyzers for PCO2 and PO2 compared with the NOVA 
analyzer, was similar to the precision of  the ABL com- 
pared with the NOVA. The bias -4- precision of  the 
I R M A  analyzers for pH measurements also appears 
different f rom that of  the ABL, when each is compared 
with the NOVA. The limits of  agreement, however, 
defined as two standard deviations above and below the 










[] Data po in ts (n=166)  
- - -  Bias 
. . . . .  Upper  l imit of agreement  
....... Lower limit of agreement  
I:1 
-0.2 
7 . 2  7 . 3  7 . 4  7 . 5  7 . 6  
Mean pH (Nova, ABL) 
l B .  
¢ 












[] Data po in ts(n=169)  
- - -  Bias 
. . . . .  Upper  limit of agreement  
. . . . .  Lower limit of agreement  
[] [] 
. . . . . . . . .  _ ~ , " " ~  . . . . . . . .  i l  . . . . . . .  , ~ _  _ " ' " ' " ~ ' " a "  . . . . . . . . . . .  ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
[] ~ [] D B [] 
. . . .  -~ . . . .  ~ ~ " a ~ . r # ' # j ~ ' E , ~ . - o ~ ' ~ . - - - - - ' - ;  . . . . . .  
B u, . ' [ ] l ~ " d ~ [ ] -  IB" 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  ' ~ . . . . "  . . . . . . . . . . . . .  [ ]?  , . . .  . . . . . . . . . .  ~ . . . . . . "  . . . "  . . . . . . . . . . . . . . . . . . . . . . . . . .  [ ]  . . . . . . . .  
[] [] 
-0,2 i , , i 
7 . 2  7 . 3  7 . 4  7 . 5  7 . 6  
Mean pit (Nova, IRMA 1) 
0 . 2 -  
m Data points (n=166) 
- - - NE bias 
. . . . .  Upper  limit of agreement  




_ [ ] [ ]  ~ [ ] , , p a . ~  _ . ~  [] 
o.o . . . . . . .  ~ - - - ~ . - a . # [ ] - ~ , ~ # - ~ , ~ , e : ~ , , - . ~ - ~  . . . . .  ~ . . . . . .  
-0.1 
-0.2 
7 . 2  7 . 3  7 . 4  7 . 5  7 . 6  
Mean pH (Nova, IRMA 2) 
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bias, are still excellent. The degree of  imprecision, a 
variation in the pH value of  0.05, would rarely be 
significant clinically. 
The limits o£ agreement comparing the ABL with the 
NOVA are smaller than those for either IRMA machine 
compared with the NOVA for PCO2 values, and are the 
same for PO2 values. The difference in the possible range 
of  agreement for the IRMA machines versus the ABL 
machine, however, does not appear to be clinically 
significant (5.6 m m H g  for the ABL versus 7 to 8 m m H g  
for the IRMA). 
In addition to the irreducible variability in analyzer 
results, another, often greater, source of  error in blood 
gas analysis occurs during sample handling. The addition 
of  even small amounts of  air, too much or too little 
heparin, or delays in analysis with the sample at room 
temperature, can introduce substantial error [1-4]. The 
small size of  the IR MA machines permits true "point-of- 
care" blood gas analysis, and thus eliminates many of  
these handling errors. The very small size also may 
permit use of  this blood gas analyzer during field resusci- 
tation and during transport (ambulance and med flight), 
an option that is not available at present. Finally, the 
disposable nature of  the cartridges reduces the risk of  
nosocomial infections. An outbreak of  Pseudornonas cepa- 
cia bacteremia (14 episodes) associated with a contami- 
nated blood gas analyzer has been reported [6]. Benchtop 
blood gas analyzers aspirate blood into the electrodes, 
which are rinsed and reused over a period of  weeks to 
months. The I R MA technology permits disposal of  the 
entire blood sample following analysis. 
In most settings, the cost of  analysis per sample will be 
lower with this technology than with current benchtop 
analyzers. The hardware cost of  the I R M A  analyzer is 
approximately one-tenth of  the cost of  an average bench- 
top analyzer. Although the disposable costs are some- 
what higher per sample with the IRMA compared with 
the benchtop disposables, maintenance costs are expected 
to be much lower for the IRMA. 
There are certain limitations associated with this new 
technology. Changes in temperature will affect the equi- 
librium of  the bicarbonate and CO2 inside the foil 
wrappers. Cartridges therefore should not be used until 
they have spent at least 24 hours in the environment in 
which they will be used. In current hospital and clinical 
settings, which have excellent environmental control, 
temperature does not fluctuate more than a few degrees 
throughout the entire building. In the field and during 
transport, however, temperature fluctuations may affect 
calibration more significantly. 
Another limitation of  this calibration method is that 
once the foil wrapper is opened, the CO2 surrounding 
the electrode will begin to dissipate. Package instructions 
state that the cartridge should be inserted into the 
machine and calibration begun within 5 minutes of  
opening the foil wrapper. While this can be easily accom- 
plished, use of  electrodes that have been exposed to 
room air for long durations will result in calibration 
errors and subsequent errors in PCO2 results. Finally, 
methods of  ensuring quality control need to be reeval- 
uated for this new technology. Standard quality control 
for benchtop analyzers involves analysis of  known con- 
trol solutions on a daily or shift basis. This permits 
recognition and replacement of  an electrode that fails to 
calibrate. Because each electrode (and cartridge) is dis- 
posable, testing known solutions will test the calibration 
and accuracy of  only the electrodes in that cartridge. The 
next cartridge may or may not calibrate to the same 
accuracy as the cartridge used to analyze the known 
sample. It may be more valuable to test each lot group, 
or to test representative samples of  a box of  cartridges 
that has been moved to a new environment. The accu- 
racy and precision of  the IRMA  system demonstrated in 
this study indicate that calibration is very consistent 
from cartridge to cartridge, and lot to lot. 
In conclusion, the I R M A  blood gas analyzer offers 
point-of-care blood gas analysis with an accuracy and 
precision that is similar to that of  current benchtop 
analyzers. 
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